Efficacy and safety of non-conventional synthetic disease-modifying antirheumatic drugs in early active rheumatoid arthritis: a network meta-analysis
BMC Rheumatol. 2025 Dec 5. doi: 10.1186/s41927-025-00603-x. Online ahead of print. ABSTRACT OBJECTIVE: To compare the clinical efficacy and safety […]

